Sveriges mest populära poddar
MDS Podcast
Vetenskap

Targeting alpha synuclein in early Parkinson's disease. Clinical trials and future perspectives

20 mars 2023
Two clinical trials with antibodies targeting alpha synuclein in early Parkinson's disease have been published in the New England Journal of Medicine. Anthony Lang and Gennaro Pagano, the first authors of the articles share the results and discuss the possible future perspectives with the MDS Podcast editor, Michele Matarazzo. Read the prasinezumab article. Read the cinpanemab article.

Fler avsnitt av MDS Podcast

Visa alla avsnitt av MDS Podcast
Hot Topic: Argentine tango in the rehabilitation of persons with Parkinson's disease
Blocking alpha-synuclein propagation with perampanel
End of life preferences of people with Parkinson's disease
Quality of life in Parkinson’s disease
New data to reframe the risks of DBS surgery for patients and providers
Ataxia Series: Treating cerebellar ataxia in 2026 - What's new?
Prodromal autonomic dysfunction in Lewy body diseases
Ataxia Series: Beyond the cerebellum - Non-motor features and multisystem care in genetic ataxias
Modulating the peripheral immune response: LRRK2 and GBA1 mutations
Ataxia Series: Neuroimaging patterns not to miss in ataxia

MDS Podcast med International Parkinson and Movement Disorder Society finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.